Cubero, Francisco Javier

Breaking the barriers: the role of gut homeostasis in Metabolic-Associated Steatotic Liver Disease (MASLD)

Benedé-Ubieto, R., Cubero, F. J., & Nevzorova, Y. A. (2024) · Gut Microbes

Liver Disease Diagnosis and TreatmentGut microbiota and health

Cited by 242

Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC

Sydor, S., Best, J., Messerschmidt, I., Manka, P., Vilchez-Vargas, R., Brodesser, S., Lucas, C., Wegehaupt, A., Wenning, C., Aßmuth, S., et al. (2020) · Clinical and Translational Gastroenterology

Gut microbiota and healthLiver Disease Diagnosis and Treatment

Cited by 127

c-MYC—Making Liver Sick: Role of c-MYC in Hepatic Cell Function, Homeostasis and Disease

Zheng, K., Cubero, F., & Nevzorova, Y. (2017) · Genes

Liver physiology and pathologyCancer-related Molecular Pathways

Cited by 84

The Space of Disse: The Liver Hub in Health and Disease

Sanz-García, C., Fernández-Iglesias, A., Gracia-Sancho, J., Arráez-Aybar, L. A., Nevzorova, Y. A., & Cubero, F. J. (2021) · Livers

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 57

Lipid-encapsulated siRNA for hepatocyte-directed treatment of advanced liver disease

Woitok, M. M., Zoubek, M. E., Doleschel, D., Bartneck, M., Mohamed, M. R., Kießling, F., Lederle, W., Trautwein, C., & Cubero, F. J. (2020) · Cell Death & Disease

RNA Interference and Gene DeliveryLiver physiology and pathology

Cited by 53

Curcumin encapsulated in milk small extracellular vesicles as a nanotherapeutic alternative in experimental chronic liver disease

Albaladejo-García, V., Morán, L., Santos-Coquillat, A., González, M. I., Ye, H., Vázquez Ogando, E., Vaquero, J., Cubero, F. J., Desco, M., & Salinas, B. (2024) · Biomedicine & Pharmacotherapy

Extracellular vesicles in diseaseCurcumin's Biomedical Applications

Cited by 32

Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model

Hatting, M., Spannbauer, M., Peng, J., Al Masaoudi, M., Sellge, G., Nevzorova, Y. A., Gassler, N., Liedtke, C., Cubero, F. J., & Trautwein, C. (2015) · Cell Death & Disease

Cytokine Signaling Pathways and InteractionsLiver physiology and pathology

Cited by 30

Inhibition of Farnesoid-x-receptor signaling during abdominal sepsis by dysbiosis exacerbates gut barrier dysfunction

Qian, S., Su, Z., Lin, J., Hou, Q., Wang, X., Li, Y., Wang, J., Huang, C., Wang, Z., Cubero, F. J., et al. (2025) · Cell Communication and Signaling

Gut microbiota and healthSepsis Diagnosis and Treatment

Cited by 24